Advanced Search

column
Research Progress in Epigenetics of Pancreatitis-cancer Transformation
YUE Ming, XU Haiyan, ZHANG Xiaofei, WANG Liwei
2021, 48(3): 219-223. DOI: 10.3971/j.issn.1000-8578.2021.20.0977
Abstract FullText HTML PDF
Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma
LIN Jian, WANG Haibo, SHEN Feng
2021, 48(3): 224-228. DOI: 10.3971/j.issn.1000-8578.2021.20.1248
Abstract FullText HTML PDF
Research Progress of Immune Checkpoint Therapy on Colorectal Cancer
CAO Qihua, XU Yanbo, XU Dong
2021, 48(3): 229-233. DOI: 10.3971/j.issn.1000-8578.2021.20.1060
Abstract FullText HTML PDF
Role and Possible Mechanism of LncRNA-MEG3 and KLF4 in Carcinogenesis and Progression of Nasopharyngeal Carcinoma
NING Jiayu, BAO Weiijing, ZHOU Sujuan, WEI Rifu, ZHU Zhongshou
2021, 48(3): 234-238. DOI: 10.3971/j.issn.1000-8578.2021.20.0790
Abstract FullText HTML PDF
Mechanism of Bicalutamide to Breast Cancer Cell Lines MDA-MB-453 and Inhibitory Effects of Its Combination with Everolimus
ZHANG Yuqin, LU Yunfei, ZHANG Haitian
2021, 48(3): 239-243. DOI: 10.3971/j.issn.1000-8578.2021.20.0819
Abstract FullText HTML PDF
LncRNA WT1-AS Knockdown Promotes Invasion and Migration of Triple Negative Breast Cancer MDA-MB-231 Cells
SHU Jiawu, LI Xijun, ZHU Liqin, WANG Yanyan
2021, 48(3): 244-247. DOI: 10.3971/j.issn.1000-8578.2021.20.0744
Abstract FullText HTML PDF
Anti-hepatocellular Carcinoma Activity and Related Mechanism of Apigenin-7-O-Glucoside
HU Xinyu, DONG Ruitao, LI Zhiping, DU Lin, LIU Yan
2021, 48(3): 248-254. DOI: 10.3971/j.issn.1000-8578.2021.20.0796
Abstract FullText HTML PDF
Expression of LncRNA DLEU1 in Esophageal Squamous Cell Carcinoma and Its Effect on Proliferation and Migration of ESCC Cells
DUAN Yuqing, WANG Yu, WANG Xuexiao, LIU Lihua
2021, 48(3): 255-260. DOI: 10.3971/j.issn.1000-8578.2021.20.0749
Abstract FullText HTML PDF
Clinicopathological Characteristics and Prognosis of Borrmann Type Ⅳ Gastric Cancer
DING Pingan, YANG Peigang, TIAN Yuan, LIN Yecheng, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun
2021, 48(3): 261-267. DOI: 10.3971/j.issn.1000-8578.2021.20.0770
Abstract FullText HTML PDF
Metabolic Syndrome and Risk of Gastric Cancer: A Meta-analysis
LIANG Tong, LIU Huajie, DA Mingxu
2021, 48(3): 268-273. DOI: 10.3971/j.issn.1000-8578.2021.20.0957
Abstract FullText HTML PDF
Bibliometric Analysis of Global Research on Colorectal Cancer Based on SCI-E
XU Zhiyong, WEI Shaozhong
2021, 48(3): 274-280. DOI: 10.3971/j.issn.1000-8578.2021.20.1475
Abstract FullText HTML PDF
Predictive Value of Tumor Mutation Burden for PD-1/PD-L1 Inhibitors Treatment on Non-small Cell Lung Cancer: A Meta-analysis
SHEN Shijun, WANG Qiaoli, YANG Jinjiang, LI Guojian, LI Mengli, ZHANG Xiaoli, GAN Ping
2021, 48(3): 281-287. DOI: 10.3971/j.issn.1000-8578.2021.20.0765
Abstract FullText HTML PDF
Progress in One-carbon Metabolism and Tumor Therapy
CHAI Dongqi, WANG Weixing
2021, 48(3): 288-292. DOI: 10.3971/j.issn.1000-8578.2021.20.0420
Abstract FullText HTML PDF
Research Progress on Relation Between Shift Work and Ovarian Cancer
GAO Chang, ZHANG Shuang, WEN Zhaoyan, GONG Tingting, ZHAO Yuhong, WU Qijun
2021, 48(3): 293-298. DOI: 10.3971/j.issn.1000-8578.2021.20.0675
Abstract FullText HTML PDF
Research Progress of Targeted Molecular Carrier for Bladder Cancer
YAN Pengyu, YAN Xutao, YANG Yongjun, YANG Xiaofeng
2021, 48(3): 299-302. DOI: 10.3971/j.issn.1000-8578.2021.20.0681
Abstract FullText HTML PDF
Reviews on TCM in Reversing Chemotherapy Resistance of Osteosarcoma from ABC Transmembrane Protein
DING Juxian, XIE Xingwen, XU Wei, LI Dingpeng, LI Ning, SU Jiliang, LIU Bo, LI Jianguo, CHAI Lijun
2021, 48(3): 303-306. DOI: 10.3971/j.issn.1000-8578.2021.20.0623
Abstract FullText HTML PDF
Research Progress of Nano-drug Delivery System Targeting Tumor-associated Macrophage in Cancer Treatment
WANG Chenchen, DU Chao, GUO Xueling, ZHANG Xiyue, WANG Yingze
2021, 48(3): 307-313. DOI: 10.3971/j.issn.1000-8578.2021.20.0724
Abstract FullText HTML PDF
Tie2 Expressing Monocytes/Macrophages in Human Tumors
JIANG Chuyi, CAI Jing, WANG Zehua, CHEN Yuanyuan
2021, 48(3): 314-318. DOI: 10.3971/j.issn.1000-8578.2021.20.1145
Abstract FullText HTML PDF
Bluebird Bio, Inc. Suspends Clinical Trial of Sickle Cell Gene Therapy: Two Subjects Develop Cancer, etc
2021, 48(3): 319-320. DOI: 10.3971/j.issn.1000-8578.2021.03.0001
Abstract FullText HTML PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：